Related Experiment Video
Updated: Aug 4, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Practical advice on eradicating Helicobacter pylori infection
D Y Graham1, R E Rakel, A M Fendrick
1Department of Medicine, Baylor College of Medicine, Houston, TX, USA. dygraham@bcm.tmc.com
Helicobacter pylori (H pylori) infection causing peptic ulcer disease is curable with effective 14-day triple-drug therapy. Confirming eradication post-treatment is crucial for successful H pylori eradication and preventing antibiotic resistance.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Peptic ulcer disease (PUD) is often caused by Helicobacter pylori (H pylori) infection.
- Effective H pylori eradication is essential for PUD cure and preventing recurrence.
Purpose of the Study:
- To outline optimal therapeutic strategies for H pylori eradication.
- To emphasize factors influencing treatment selection, including efficacy, resistance, adverse effects, compliance, and cost.
Main Methods:
- Review of current therapeutic regimens for H pylori infection.
- Emphasis on combination therapies including bismuth or antisecretory drugs with two antibiotics for 14 days.
- Discouragement of dual-drug therapies due to lower efficacy and higher resistance risk.
Main Results:
- Triple-drug regimens demonstrate higher H pylori eradication rates.
- 14-day triple-drug therapy minimizes the development of antibiotic resistance.
- Confirmation of H pylori cure 4 weeks post-treatment is recommended.
Conclusions:
- Effective H pylori eradication is achievable with appropriate multi-drug therapy.
- Patient compliance and antibiotic stewardship are critical for successful treatment outcomes.
- Managed care considerations should align with best medical practices for H pylori treatment.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology